Leading a Culture of Innovation

Recent News

Read written Recent News About IP and Technology

Vintag.es

2026

The Legal Battle of Robert Kearns, Who Invented the Intermittent Windshield Wiper, vs. Ford Motor Company

In 1963, Robert Kearns, an engineer with a PhD, invented the intermittent windshield wiper. Inspired by the human eye—which blinks only when......

Read More
GlobeNewswire

2026

GRI Bio to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial

– Live video webcast on Wednesday, February 11th at 1:00 PM EST  LA JOLLA, CA, Feb. 05, 2026 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio”......

Read More
GlobeNewswire

2026

Longeveron Applauds Passage of the Mikaela Naylon Give Kids a Chance Act and Reauthorization of Rare Pediatric Disease Priority Review Voucher Program

Longeveron supports the passing of the Mikaela Naylon Give Kids a Chance Act which reauthorizes the Rare Pediatric Disease Priority Review Voucher Program....

Read More
GlobeNewswire

2026

AIM ImmunoTech Reports Positive Year-End Interim Clinical Progress from Phase 2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi® (durvalumab) for the Treatment of Pancreatic Cancer

Year-end report discusses combination therapy’s Mechanism of Action activating both innate and adaptive immune responses Year-end report discusses combination therapy’s Mechanism of Action activating both innate and adaptive immune responses...

Read More
Financial Post

2026

ZenaTech’s Drone as a Service Announces Initiation of its Golf Course Survey Services Across Florida

VANCOUVER, British Columbia, Feb. 05, 2026 (GLOBE NEWSWIRE) — ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), a technology solution provider specializing in AI (Artificial Intelligence) drone, Drone as a Service (DaaS), enterprise SaaS, and…...

Read More
GlobeNewswire

2026

FibroBiologics Announces Issuance of Canadian Patent Covering Novel Fibroblast-Based Treatment for Cachexia

HOUSTON, Feb. 05, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures…...

Read More
Our Insights

Insight, Story & Blog

Patent Cases to Watch in the Second Half of 2024: Implications for IP Strategy

Read More

The Intricacies of AAA Commercial Arbitration: A Comprehensive Guide for Legal Professionals

Read More

Navigating the Maze of Trademark Confusion: Key Considerations for Brand Owners

Read More
Get in Touch

Ready to work
together? Let's go!

MC Law loves hearing from you. Send us a message to inquire how we can solve your legal issues.

Phone: +1 202.409.1003

Email: contact@mclaw.io

Professionals
Located in

OFFICES